The function of the DataBase Shared Resource (DBSR) is to develop, integrate, and maintain a centralized, cost-effective, and well-characterized research database encompassing all the Herbert Irving Comprehensive Cancer Center (HICCC) tumor registries. Directed by Jeanine Genkinger, PhD and Katherine Crew, MD, MS, the DBSR has, over the past five years, developed a standardized protocol with universal consent of individuals with cancer or at risk for cancer to promote novel and innovative cancer research within the HICCC, as well as the larger Columbia University Irving Medical Center (CUIMC) community. The DBSR provides oversight and infrastructure for the development and maintenance of a cancer-related research database across multiple cancer subspecialties including: (1) integration of all prior adult solid tumor registries into one standardized protocol; (2) development of a retrospective cohort of patients through linkage of data from electronic health records (EHRs) across multiple platforms and data warehouses (i.e., New York-Presbyterian Hospital [NYPH] Tumor Registry) with existing residual tissue samples; and (3) development and maintenance of a prospective cohort implemented through consenting, collecting biospecimens (e.g., blood, saliva) and epidemiologic data (e.g., lifestyle factors), and linking to data from the EHR/NYPH Tumor Registry and residual tissue samples. DBSR also coordinates research database-related services with other Shared Resources. In addition, DBSR provides support to the research community by: (1) incorporating recruitment to ancillary studies in the cancer clinics via recruitment staff, (2) reviewing requests to access the cancer-related research database via a dedicated Scientific Review Committee and tracking utilization of requests (i.e., manuscripts published, funding awarded), and (3) disseminating information about the cancer-related research database to the research and lay community to promote novel and innovative cancer research. Over the current project period (2014-2019), DBSR integrated 24 clinical registries into one overarching research database. Due to highly qualified and bilingual recruiters, DBSR has met its accrual targets and enrolled over 4,700 individuals, from whom DBSR has collected over 2,400 biospecimens, and over 2,600 questionnaires. To foster highly innovative research, the DBSR has approved and fulfilled over 120 data and biospecimen requests and supported over 10 ancillary studies through efficient enrollment and data extraction. Through this, the DBSR has supported several federally funded grants. Over the current project period, the capabilities of the DBSR have been utilized by 35 HICCC members and supported key data and insights for 31 HICCC member peer-reviewed publications, including five papers with impact factor >10 and manuscripts in reference cancer journals (e.g., Cancer Epidemiology, Biomarkers & Prevention, Clinical Cancer Research, Cancer Prevention Research). Currently DBSR support research in three NCI-funded research project grants.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013696-45
Application #
10022768
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-07-04
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Ghorpade, Devram S; Ozcan, Lale; Zheng, Ze et al. (2018) Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. Nature 555:673-677
Jauregui, Ruben; Thomas, Amanda L; Liechty, Benjamin et al. (2018) SCAPER-associated nonsyndromic autosomal recessive retinitis pigmentosa. Am J Med Genet A :
Jauregui, Ruben; Park, Karen Sophia; Duong, Jimmy K et al. (2018) Quantitative Comparison of Near-infrared Versus Short-wave Autofluorescence Imaging in Monitoring Progression of Retinitis Pigmentosa. Am J Ophthalmol 194:120-125
Bianchetti, E; Bates, S J; Carroll, S L et al. (2018) Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors. Sci Rep 8:17390
Shang, Enyuan; Zhang, Yiru; Shu, Chang et al. (2018) Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems. Sci Rep 8:15383
Proto, Jonathan D; Doran, Amanda C; Subramanian, Manikandan et al. (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128:2370-2375
Apatoff, Mary Ben L; Sengillo, Jesse D; White, Eugenia C et al. (2018) Autologous stem cell therapy for inherited and acquired retinal disease. Regen Med 13:89-96
Shen, Megan Johnson; Prigerson, Holly G; Ratshikana-Moloko, Mpho et al. (2018) Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa. J Glob Oncol :1-9
Connors, Thomas J; Baird, J Scott; Yopes, Margot C et al. (2018) Developmental Regulation of Effector and Resident Memory T Cell Generation during Pediatric Viral Respiratory Tract Infection. J Immunol 201:432-439
Billing, David; Horiguchi, Michiko; Wu-Baer, Foon et al. (2018) The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection. Mol Cell 72:127-139.e8

Showing the most recent 10 out of 331 publications